Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

purpura/radang

Tautan disimpan ke clipboard
Halaman 1 dari 36 hasil
The invention relates to the use of complement inhibitors, especially of C1 inactivator or of factors I or H, for the preparation of a pharmaceutical for the prophylaxis and therapy of chronic inflammatory intestinal disorders, inflammatory skin disorders and purpura. The complement system is

Substituted quinolines and their uses in treatment of inflammatory and related conditions

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods, of using such materials. BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a
TECHNICAL FIELD OF THE INVENTION This invention relates to isolated short peptides comprising the amino acid sequence Cys-Glu-Phe-His (CEFH; SEQ ID NOS: 1 and 15) and analogs thereof as well as compositions comprising CEFH peptides and analogs thereof. The CEFH peptides disclosed herein are

Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca.sup.2+ activated potassium channel (IK.sub.Ca), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune

Amino O-aryl macrolides having immunosuppressive activity

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SUMMARY OF THE INVENTION The present invention is related to amino O-aryl macrolides and derivatives which are useful in a mammalian host for the treatment of autoimmune diseases (such as juvenile-onset or recent-onset diabetes mellitus, multiple sclerosis, rheumatoid arthritis, liver disease,

Alkylidene macrolides having immunosuppressive activity

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SUMMARY OF THE INVENTION The present invention is related to alkylidene macrolides which are useful in a mammalian host for the treatment of autoimmune diseases (such as juvenile-onset diabetes mellitus, multiple sclerosis and rheumatoid arthritis), immunodepression, infectious diseases and/or the

Alkyl and alkenyl macrolides having immunosuppressive activity

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SUMMARY OF THE INVENTION The present invention is related to alkyl and alkenyl macrolides which are useful in a mammalian host for the treatment of autoimmune diseases (such as juvenile-onset diabetes mellitus, multiple sclerosis and rheumatoid arthritis), immunodepression, infectious diseases

O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention is related to O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides which are useful in a mammalian host for the treatment of autoimmune diseases (such as juvenile-onset or recent-onset diabetes mellitus, multiple sclerosis, rheumatoid arthritis, liver disease, posterior uveitis,

Quinoline derivitives and their uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials. BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a

Quinolines for the treatment of PI3K-.delta. mediated diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials. Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a

Heterocyclic compounds and their uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials. BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a

Heterocyclic compounds and their uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a variety of cellular processes, e.g., malignant transformation, growth factor signaling, inflammation, and immunity (see Rameh et al., J. Biol Chem, 274:8347-8350 (1999) for a review). The

Heterocyclic compounds and their uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a variety of cellular processes, e.g., malignant transformation, growth factor signaling, inflammation, and immunity (see Rameh et al., J. Biol Chem, 274:8347-8350 (1999) for a review). The

Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials. BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a

Heterocyclic compounds and their uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials. BACKGROUND OF THE INVENTION Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a
Bergabunglah dengan
halaman facebook kami

Database tanaman obat terlengkap yang didukung oleh sains

  • Bekerja dalam 55 bahasa
  • Pengobatan herbal didukung oleh sains
  • Pengenalan herbal melalui gambar
  • Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
  • Baca publikasi ilmiah yang terkait dengan pencarian Anda
  • Cari tanaman obat berdasarkan efeknya
  • Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten

Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan

Google Play badgeApp Store badge